Edition:
United States

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

25.00USD
10:20am EST
Change (% chg)

$0.45 (+1.83%)
Prev Close
$24.55
Open
$24.70
Day's High
$25.10
Day's Low
$24.70
Volume
15,497
Avg. Vol
40,758
52-wk High
$28.65
52-wk Low
$15.95

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.98 December 22 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 6 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 0.07 0.10 0.00 0.10
Quarter Ending Mar-18 2 0.09 0.10 0.08 0.10
Year Ending Dec-17 7 0.26 0.40 0.00 0.28
Year Ending Dec-18 7 0.23 0.60 0.00 0.35
Earnings (per share)
Quarter Ending Dec-17 6 -0.98 -0.90 -1.02 -0.89
Quarter Ending Mar-18 2 -0.71 -0.71 -0.72 -0.78
Year Ending Dec-17 6 -3.77 -3.25 -3.96 -3.22
Year Ending Dec-18 7 -3.52 -2.87 -4.24 -3.02

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.05 0.08 0.03 50.00
Quarter Ending Jun-17 0.05 0.08 0.03 50.00
Quarter Ending Mar-17 0.06 0.08 0.01 20.00
Quarter Ending Dec-16 0.07 0.08 0.01 13.64
Quarter Ending Sep-16 0.06 0.08 0.01 17.55

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.07 0.07 0.05 0.05 0.10
Quarter Ending Mar-18 0.09 0.10 0.10 0.10 0.10
Year Ending Dec-17 0.26 0.25 0.22 0.27 0.28
Year Ending Dec-18 0.23 0.22 0.22 0.26 0.35

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 2 0
Year Ending Dec-18 0 0 0 0
Earnings